The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Autoimmune heparin‐induced thrombocytopenia
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Treatment and Prevention of Heparin-Induced Thrombocytopenia
Linkins, L.-A., Dans, A. L., Moores, L. K., Bona, R., Davidson, B. L., Schulman, S., & Crowther, M. (2012) · Chest · doi:10.1378/chest.11-2303 · Cited by 1,018
Temporal Aspects of Heparin-Induced Thrombocytopenia
Warkentin, T. E., & Kelton, J. G. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104263441704 · Cited by 977
Self-citationT Cell Antigen Receptor Recognition of Antigen-Presenting Molecules
Rossjohn, J., Gras, S., Miles, J. J., Turner, S. J., Godfrey, D. I., & McCluskey, J. (2015) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032414-112334 · Cited by 797
Heparin-Induced Thrombocytopenia
Greinacher, A. (2015) · New England Journal of Medicine · doi:10.1056/nejmcp1411910 · Cited by 608
Self-citationMedical device‐induced thrombosis: what causes it and how can we prevent it?
Jaffer, I. H., Fredenburgh, J. C., Hirsh, J., & Weitz, J. I. (2015) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12961 · Cited by 557
Heparin‐induced thrombocytopenia: pathogenesis and management
Warkentin, T. E. (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04334.x · Cited by 547
Self-citationInteractions between coagulation and complement—their role in inflammation
Oikonomopoulou, K., Ricklin, D., Ward, P. A., & Lambris, J. D. (2012) · Seminars in Immunopathology · doi:10.1007/s00281-011-0280-x · Cited by 486
Delayed-Onset Heparin-Induced Thrombocytopenia and Thrombosis
Warkentin, T. E., & Kelton, J. G. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-7-200110020-00009 · Cited by 467
Self-citationHeparin-Induced Thrombocytopenia Associated with Fondaparinux
(2007) · New England Journal of Medicine · doi:10.1056/nejmc070346 · Cited by 283
Delayed-Onset Heparin-Induced Thrombocytopenia
Rice, L., Attisha, W. K., Drexler, A., & Francis, J. L. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-136-3-200202050-00009 · Cited by 265
Direct oral anticoagulants for treatment of HIT: update of Hamilton experience and literature review
Warkentin, T. E., Pai, M., & Linkins, L.-A. (2017) · Blood · doi:10.1182/blood-2017-04-778993 · Cited by 210
Self-citationCrystal Structure of Recombinant Human Platelet Factor 4
Zhang, X., Chen, L., Bancroft, D. P., Lai, C. K., & Maione, T. E. (1994) · Biochemistry · doi:10.1021/bi00193a025 · Cited by 179
A Spontaneous Prothrombotic Disorder Resembling Heparin-induced Thrombocytopenia
Warkentin, T. E., Makris, M., Jay, R. M., & Kelton, J. G. (2008) · The American Journal of Medicine · doi:10.1016/j.amjmed.2008.03.012 · Cited by 170
Self-citationJaax, M. E., Krauel, K., Marschall, T., Brandt, S., Gansler, J., Fürll, B., Appel, B., Fischer, S., Block, S., Helm, C. A., et al. (2013) · Blood · doi:10.1182/blood-2013-01-478966 · Cited by 162
Self-citationGreinacher, A., Gopinadhan, M., Günther, J.-U., Omer-Adam, M. A., Strobel, U., Warkentin, T. E., Papastavrou, G., Weitschies, W., & Helm, C. A. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000238350.89477.88 · Cited by 161
Self-citationWarkentin, T. E., Basciano, P. A., Knopman, J., & Bernstein, R. A. (2014) · Blood · doi:10.1182/blood-2014-01-549741 · Cited by 158
Self-citationIVIg for Treatment of Severe Refractory Heparin-Induced Thrombocytopenia
Padmanabhan, A., Jones, C. G., Pechauer, S. M., Curtis, B. R., Bougie, D. W., Irani, M. S., Bryant, B. J., Alperin, J. B., DeLoughery, T. G., Mulvey, K. P., et al. (2017) · CHEST Journal · doi:10.1016/j.chest.2017.03.050 · Cited by 146
Atomic description of the immune complex involved in heparin-induced thrombocytopenia
Cai, Z., Yarovoi, S. V., Zhu, Z., Rauova, L., Hayes, V., Lebedeva, T., Liu, Q., Poncz, M., Arepally, G. M., Cines, D. B., et al. (2015) · Nature Communications · doi:10.1038/ncomms9277 · Cited by 145
Warkentin, T. E., Pai, M., Sheppard, J. I., et al. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2011.04487.x · Cited by 137
Self-citationKang, M. S., Alahmadi, M. D., Sawh, S. C., Kovacs, M. J., & Lazo‐Langner, A. (2014) · Blood · doi:10.1182/blood-2014-09-599498 · Cited by 134
Platelet factor 4 binding to lipid A of Gram-negative bacteria exposes PF4/heparin-like epitopes
Krauel, K., Weber, C., Brandt, S. V., Zähringer, U., Mamat, U., Greinacher, A., & Hammerschmidt, S. (2012) · Blood · doi:10.1182/blood-2012-06-434985 · Cited by 130
Self-citationβ2-Glycoprotein I: a novel component of innate immunity
Ağar, Ç., de Groot, P. G., Mörgelin, M., Monk, S. D. D. C., OS, G. M. A. V., Levels, J. H. M., de Laat, B., Urbanus, R. T., Herwald, H., van der Poll, T., et al. (2011) · Blood · doi:10.1182/blood-2010-12-325951 · Cited by 122
Anti-platelet factor 4/polyanion antibodies mediate a new mechanism of autoimmunity
Nguyen, T., Medvedev, N., Delcea, M., & Greinacher, A. (2017) · Nature Communications · doi:10.1038/ncomms14945 · Cited by 121
Self-citationHeparin-Induced Thrombocytopenia in Critically Ill Patients
Warkentin, T. E. (2015) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0034-1398381 · Cited by 118
Self-citationKrauel, K., Hackbarth, C., Fürll, B., & Greinacher, A. (2011) · Blood · doi:10.1182/blood-2011-05-353391 · Cited by 116
Self-citationIschemic Limb Gangrene with Pulses
Warkentin, T. E. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1316259 · Cited by 116
Self-citationHeparin-induced anaphylactic and anaphylactoid reactions: two distinct but overlapping syndromes
Warkentin, T. E., & Greinacher, A. (2009) · Expert Opinion on Drug Safety · doi:10.1517/14740330902778180 · Cited by 111
Self-citationWarkentin, T. E., & Bernstein, R. A. (2003) · New England Journal of Medicine · doi:10.1056/nejm200303133481120 · Cited by 100
Self-citationNazi, I., Arnold, D. M., Warkentin, T. E., Smith, J. W., Staibano, P., & Kelton, J. G. (2015) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13066 · Cited by 95
Self-citationFondaparinux: does it cause HIT? can it treat HIT?
Warkentin, T. E. (2010) · Expert Review of Hematology · doi:10.1586/ehm.10.54 · Cited by 89
Self-citationAnticoagulant failure in coagulopathic patients: PTT confounding and other pitfalls
Warkentin, T. E. (2013) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2013.823946 · Cited by 87
Self-citationWarkentin, T. E. (2016) · Thrombosis and Haemostasis · doi:10.1160/th16-06-0435 · Cited by 85
Self-citationBrandt, S. V., Krauel, K., Gottschalk, K. E., Renné, T., Helm, C. A., Greinacher, A., & Block, S. (2014) · Thrombosis and Haemostasis · doi:10.1160/th13-08-0634 · Cited by 84
Self-citationJay, R. M., & Warkentin, T. E. (2008) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2008.03040.x · Cited by 78
Self-citationCines, D. B., Yarovoi, S. V., Zaitsev, S. V., Lebedeva, T., Rauova, L., Poncz, M., Arepally, G. M., Khandelwal, S., Stepanova, V. V., Rux, A. H., et al. (2016) · Blood Advances · doi:10.1182/bloodadvances.2016000877 · Cited by 76
Agents for the Treatment of Heparin-Induced Thrombocytopenia
Warkentin, T. E. (2010) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2010.05.009 · Cited by 66
Self-citationPoudel, D. R., Ghimire, S., Dhital, R., Forman, D. A., & Warkentin, T. E. (2017) · Platelets · doi:10.1080/09537104.2017.1366973 · Cited by 59
Self-citationTLR3 agonists as immunotherapeutic agents
Nicodemus, C. F., & Berek, J. S. (2010) · Immunotherapy · doi:10.2217/imt.10.8 · Cited by 58
Heparin-induced thrombocytopenia presenting as bilateral adrenal hemorrhages
Warkentin, T. E., Safyan, E. L., & Linkins, L.-A. (2015) · New England Journal of Medicine · doi:10.1056/nejmc1414161 · Cited by 57
Self-citationNguyen, T., Greinacher, A., & Delcea, M. (2015) · Nanoscale · doi:10.1039/c5nr02132d · Cited by 57
Self-citationManagement of the multiple phases of heparin-induced thrombocytopenia
Cuker, A. C. (2016) · Thrombosis and Haemostasis · doi:10.1160/th16-02-0084 · Cited by 56
Heparin-induced thrombocytopenia in cardiac surgery and critically ill patients
Selleng, S., & Selleng, K. (2016) · Thrombosis and Haemostasis · doi:10.1160/th16-03-0230 · Cited by 55
Self-citationMe or not me? The danger of spontaneity
Greinacher, A. (2014) · Blood · doi:10.1182/blood-2014-04-566836 · Cited by 40
Self-citationElshoury, A., Khedr, M., Abousayed, M. M., & Mehdi, S. B. (2015) · Arthroplasty Today · doi:10.1016/j.artd.2015.07.003 · Cited by 19
Pathophysiological insights into the antiphospholipid syndrome
Manukyan, D., Müller‐Calleja, N., & Lackner, K. J. (2016) · Hämostaseologie · doi:10.5482/hamo-16-07-0020 · Cited by 4
Cited by
Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination
Greinacher, A., Thiele, T., Warkentin, T. E., Weisser, K., Kyrle, P. A., & Eichinger, S. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2104840 · Cited by 2,259
Self-citationThrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination
Schultz, N. H., Sørvoll, I. H., Michelsen, A. E., Munthe, L. A., Lund-Johansen, F., Ahlen, M. T., Wiedmann, M., Aamodt, A.-H., Skattør, T. H., Tjønnfjord, G. E., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2104882 · Cited by 1,452
The unique characteristics of COVID-19 coagulopathy
Iba, T., Levy, J. H., Connors, J. M., Warkentin, T. E., Thachil, J., & Levi, M. (2020) · Critical Care · doi:10.1186/s13054-020-03077-0 · Cited by 533
Self-citationSee, I., Su, J. R., Lale, A., Woo, E. J., Guh, A. Y., Shimabukuro, T. T., Streiff, M. B., Rao, A. K., Wheeler, A. P., Beavers, S. F., et al. (2021) · JAMA · doi:10.1001/jama.2021.7517 · Cited by 532
Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination
Muir, K.-L., Kallam, A., Koepsell, S. A., & Gundabolu, K. (2021) · New England Journal of Medicine · doi:10.1056/nejmc2105869 · Cited by 412
Metadata
- Authors
- Greinacher, A., Selleng, K., & Warkentin, T. E.
- Venue
- Journal of Thrombosis and Haemostasis
- Publisher
- Elsevier BV
- Published
- 2017-11
- Volume
- 15
- Issue
- 11
- Pages
- 2099-2114
- ISSN
- 1538-7836 (ISSN-L)
- OpenAlex
- W2749355395
- Cited by
- 406
- References
- 45
- FWCI
- 19.46
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.